Abstract: An armature molded structure includes a cylindrical iron core used for a molded structure of a motor armature; a winding; and molding resin, wherein the iron core includes first core sheets and second core sheets, the first core sheet includes first magnetic poles placed along a circumferential direction of the iron core, tip portions, on an inner peripheral side of the iron core, of adjacent first magnetic poles form a coupling portion coupling the adjacent first magnetic poles, the second core sheet includes second magnetic poles placed along the circumferential direction of the iron core, tip portions, on the inner peripheral side of the iron core, of adjacent second magnetic poles form a non-coupling portion separating the adjacent second magnetic poles, the first and second core sheets are laminated along a central axis direction of the iron core in such a manner that the coupling portions coincide with each other, the non-coupling portions coincide with each other, the coupling portion and the non-coupl

Abstract: A method according to the present invention for producing a cartilage-damage treatment agent, includes the steps of: (i) proliferating mesenchymal stem cells in a serum-free medium A containing an FGF, a PDGF, a TGF-?, an HGF, an EGF, at least one phospholipid and at least one fatty acid; and (ii) mixing the mesenchymal stem cells thus proliferated in the step (i), an isotonic preserving agent, and a cytoprotective agent. This method provides a cartilage-damage treatment agent which favorably regenerates a cartilage tissue.

Abstract: The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C1-3 alkyl group or the like; and R1, R2 and R3 each independently represent an optionally substituted linear or branched C1-4 alkyl group.

Abstract: The present invention relates to a distinct B cell subset, B10 cells, that regulate T cell mediated inflammatory responses through the secretion of interleukin-10 (IL-10). The invention also relates to the use of B10 cells in the manipulation of immune and inflammatory responses, and in the treatment of disease. Therapeutic approaches involving adoptive transfer of B10 cells, or expansion of their endogenous levels for controlling autoimmune or inflammatory diseases and conditions are described. Ablation of B10 cells, or inhibition of their IL-10 production can be used to upregulate immunodeficient conditions, ameliorate infectious diseases and/or to treat tumors/cancer. Diagnostic applications are also encompassed.

Abstract: The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C1-3 alkyl group or the like; and R1, R2 and R3 each independently represent an optionally substituted linear or branched C1-4 alkyl group.

Abstract: A communication method includes: transmitting a change request from a first conference server to a management server; determining that a second conference server is a conference server after change; transmitting an ID identifying the second conference server from the management server to the first conference server; transmitting a control request from the first conference server to the second conference server based on the ID; performing communication between the second conference server and the management server to confirm whether the second conference server is permitted to control the particular conference room; performing an initialization processing to control the particular conference room; transmitting a completion notification of initialization from the second conference server to the first conference server; transmitting a change instruction from the first conference server to each particular client; connecting each particular client with the second conference server; and disconnecting connection bet

Abstract: A pressure-sensitive adhesive composition including an addition reaction type silicone polymer as a component (A); an ultraviolet absorber as a component (B); and a platinum group metal catalyst as a component (C). The ultraviolet absorber as the component (B) includes a benzophenone-based ultraviolet absorber and its amount is set to a value within the range of 1 part to 4 parts by weight relative to 100 parts by weight of the addition reaction type silicone polymer as the component (A). The amount of the platinum group metal catalyst as the component (C) is set to a value within the range of 0.001 parts to 0.05 parts by weight relative to 100 parts by weight of the addition reaction type silicone polymer as the component (A).

Abstract: Provided is a compound represented by formula (I) or a pharmacologically acceptable salt thereof: wherein L1 is an optionally substituted C1-6 alkylene group or the like, L2 is a single bond or the like, L3 is a single bond or the like, R1, R2, and R3 are each independently an optionally substituted C1-4 alkyl group or the like, R4 is a hydrogen atom or the like, and R5 is a hydrogen atom or the like.

Abstract: The present invention relates to a distinct B cell subset, B10 cells, that regulate T cell mediated inflammatory responses through the secretion of interleukin-10 (IL-10). The invention also relates to the use of B10 cells in the manipulation of immune and inflammatory responses, and in the treatment of disease. Therapeutic approaches involving adoptive transfer of B10 cells, or expansion of their endogenous levels for controlling autoimmune or inflammatory diseases and conditions are described. Ablation of B10 cells, or inhibition of their IL-10 production can be used to upregulate immunodeficient conditions, ameliorate infectious diseases and/or to treat tumors/cancer. Diagnostic applications are also encompassed.

Abstract: A communication method includes: transmitting a change request from a first conference server to a management server; determining that a second conference server is a conference server after change; transmitting an ID identifying the second conference server from the management server to the first conference server; transmitting a control request from the first conference server to the second conference server based on the ID; performing communication between the second conference server and the management server to confirm whether the second conference server is permitted to control the particular conference room; performing an initialization processing to control the particular conference room; transmitting a completion notification of initialization from the second conference server to the first conference server; transmitting a change instruction from the first conference server to each particular client; connecting each particular client with the second conference server; and disconnecting connection bet

Abstract: The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C1-3 alkyl group or the like; and R1, R2 and R3 each independently represent an optionally substituted linear or branched C1-4 alkyl group.

Abstract: A linear motor includes an excitation unit including a shaft and a plurality of permanent magnets located in the shaft, and an armature including a plurality of coils surrounding the excitation unit and a magnetic cover covering the coils. The plurality of coils of the same phase group are continuously wound over a plurality of insulative bobbins. A tap conductor, a jumper wire between the coils, and a terminal wire of the coils in different phase groups that are continuously wound are separately disposed in different corner portions in the magnetic cover, and the terminal wire of each phase is connected to a circuit board.

Abstract: Provided is a compound represented by formula (I) or a pharmacologically acceptable salt thereof: wherein L1 is an optionally substituted C1-6 alkylene group or the like, L2 is a single bond or the like, L3 is a single bond or the like, R1, R2, and R3 are each independently an optionally substituted C1-4 alkyl group or the like, R4 is a hydrogen atom or the like, and R5 is a hydrogen atom or the like.

Abstract: Each of substrates which are sequentially loaded into an apparatus is transferred to one of empty (available) cooling units, and the cooling unit is reserved as a unit to be used for performing a cooling treatment after a post-exposure bake process for the substrate and the reservation information is stored. After one of the cooling units is reserved in advance before the post-exposure bake process, the substrate is transferred from the cooling unit to one of heating units without being subjected to a cooling treatment and is subjected to a post-exposure bake process therein. After the post-exposure bake process, the substrate is transferred from the heating unit to the reserved cooling unit which is reserved in advance and subjected to a cooling treatment therein.

Abstract: A communication method includes: receiving a first notification from a conference server, the conference server enabling a plurality of first conference clients to perform a teleconference by communication of a first method; starting up a virtual conference client in response to receiving the first notification; connecting the virtual conference client with a second conference client, the second conference client performing a teleconference by communication of a second method different from the first method; connecting the virtual conference client with the conference server in response to connection between the virtual conference client and the second conference client; transmitting first data to the second conference client by the second method, the first data being received from the conference server by the first method; and transmitting second data to the conference server by the first method, the second data being received from the second conference client by the second method.

Abstract: A communication method includes: receiving a plurality of first media data transmitted from a plurality of first conference clients by communication of a first method; transmitting the received plurality of first media data to a virtual conference client by the first method; receiving the plurality of first media data transmitted from the conference server, by the first method; mixing the received plurality of first media data to generate mixing data; transmitting the generated mixing data to a second conference client by communication of a second method; receiving second media data from the second conference client by the second method; transmitting the received second media data to the conference server by the first method; receiving the second media data transmitted from the virtual conference client, by the first method; and transmitting the received second media data to the plurality of first conference clients by the first method.

Abstract: The present invention relates to stabilization of a certain benzothia(dia)zepine derivative in a solid formulation containing the same. In the present invention, in a solid formulation containing (A) the benzothia(dia) zepine derivative mentioned above and (B) a specific plasticizer, the aforementioned ingredient (A) is isolated from the aforementioned ingredient (B), or alternatively, in the case of the aforementioned ingredient (A) not being isolated from the aforementioned ingredient (B), an amount of the aforementioned ingredient (B) is controlled to 0.

Abstract: The present invention relates to stabilization of a certain benzothia(dia)zepine derivative in a solid formulation containing the same. In the present invention, in a solid formulation containing the benzothia(dia)zepine derivative mentioned above, a combination of polyethylene glycol and polyvinyl alcohol is not blended, or alternatively, in the case of blending polyethylene glycol and polyvinyl alcohol in the solid formulation, the aforementioned derivative is isolated from the combination of polyethylene glycol and polyvinyl alcohol.

Abstract: A pressure-sensitive adhesive composition and a pressure-sensitive adhesive sheet have excellent weather resistance and contain a silicone polymer having excellent curability as a main agent. A pressure-sensitive adhesive composition includes an addition reaction type silicone polymer as a component (A); an ultraviolet absorber as a component (B); and a platinum group metal catalyst as a component (C). The ultraviolet absorber as the component (B) includes a benzophenone-based ultraviolet absorber and its amount is set to a value within the range of 1 part to 4 parts by weight relative to 100 parts by weight of the addition reaction type silicone polymer as the component (A). The amount of the platinum group metal catalyst as the component (C) is set to a value within the range of 0.001 parts to 0.05 parts by weight relative to 100 parts by weight of the addition reaction type silicone polymer as the component (A).

Abstract: Provided is a recording medium storing an information processing program including: specifying access information with respect to a web site; establishing a session between an information processing apparatus and an authentication server apparatus by causing authenticator to access the authentication server apparatus via a communication network based on the access information specified by the specifying; executing an individual identity authentication process for the information processing apparatus independently of at least one web browser in response to a response from the authentication server apparatus by using the session established by the establishing; and activating, when authentication by the individual identity authentication process succeeds, the at least one web browser, providing information of the session and the access information to the at least one web browser, and causing the at least one web browser to access the web site based on the information of the session and the access information.